InspireMD (NSPR) Income from Continuing Operations (2010 - 2025)
InspireMD (NSPR) posted quarterly Income from Continuing Operations of 75652000.0 for Q4 2025, down 30.89% year-over-year from 109470197.89 in Q4 2024, and down 479.66% quarter-over-quarter from 13051000.0 in Q3 2025.
InspireMD (NSPR) Income from Continuing Operations (2010 - 2025) Analysis & Trends
InspireMD's Income from Continuing Operations history runs 16 years deep, the most recent figure standing at 75652000.0 for Q4 2025.
- In Q4 2025, Income from Continuing Operations fell 30.89% year-over-year to 75652000.0; the TTM figure through Dec 2025 stood at 113182000.0 (down 38.14% YoY), while the FY2025 annual figure was 49894000.0, down 97.7% from the prior year.
- Income from Continuing Operations for Q4 2025 stood at 75652000.0, down from 13051000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 3243000.0 in Q1 2021, with the low at 75652000.0 in Q4 2025.
- The 5-year median for Income from Continuing Operations is 5479000.0 (2023), against an average of 13036550.0.
- The sharpest annual moves came in 2021 and 2023: Income from Continuing Operations jumped 89.57% in 2021, then sank 251.69% in 2023.
- InspireMD's Income from Continuing Operations stood at 4052000.0 in 2021, then declined by 18.88% to 4817000.0 in 2022, then tumbled by 251.69% to 16941000.0 in 2023, then plunged by 241.17% to 57797000.0 in 2024, then sank by 30.89% to 75652000.0 in 2025.
- Business Quant data shows NSPR's Income from Continuing Operations at 75652000.0 in Q4 2025, 13051000.0 in Q3 2025, and 13019000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | InspireMD | 57.97 Mn | 3.76 Mn | 1.18 Mn | -12.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -75.65 Mn |
| Sep 30, 2025 | -13.05 Mn |
| Jun 30, 2025 | -13.02 Mn |
| Mar 31, 2025 | -11.46 Mn |
| Dec 31, 2024 | -57.80 Mn |
| Sep 30, 2024 | -8.46 Mn |
| Jun 30, 2024 | -8.26 Mn |
| Mar 31, 2024 | -7.41 Mn |
| Dec 31, 2023 | -16.94 Mn |
| Sep 30, 2023 | -5.64 Mn |
| Jun 30, 2023 | -5.32 Mn |
| Mar 31, 2023 | -4.38 Mn |
| Dec 31, 2022 | -4.82 Mn |
| Sep 30, 2022 | -4.53 Mn |
| Jun 30, 2022 | -4.64 Mn |
| Mar 31, 2022 | -4.48 Mn |
| Dec 31, 2021 | -4.05 Mn |
| Sep 30, 2021 | -4.07 Mn |
| Jun 30, 2021 | -3.51 Mn |
| Mar 31, 2021 | -3.24 Mn |